stars 1 stars 2 stars 3

Epizyme is dedicated to rewriting treatment for people with cancer through targeted epigenetic medicines. We aspire to change the standard of care for patients and physicians by developing medicines with fundamentally new mechanisms of action directed at specific causes of hematological malignancies and solid tumors. Our research is yielding exciting new targets for which we are developing novel small molecule programs with the goal of expanding on a pipeline of clinical candidates. Our exceptional team is dedicated to bringing epigenetic therapies to the many patients who need them. Learn more at www.epizyme.com. For our community guidelines, visit https://epzy.me/communityguidelines.

Epizyme Questions

The Epizyme annual revenue was $3.7 billion in 2026.

13 people are employed at Epizyme.

Epizyme is based in Cambridge, Massachusetts.

The NAICS codes for Epizyme are [32, 32541, 541, 325, 3254, 54].

The SIC codes for Epizyme are [283, 28].

Top Epizyme Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users